Clinical Trial Update: Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a vaccine therapy for recurrent prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED